What Do FTC’s Aggressive Moves Against Biopharma Portend For 2024?

 
• By Brenda Sandburg
  
FTC statue - pink perspectives
US Federal Trade Commission derailed or restricted several transactions last year. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet